Home Smart phones Pill gross sales maintain falling, Apple nonetheless leads

Pill gross sales maintain falling, Apple nonetheless leads

0
Pill gross sales maintain falling, Apple nonetheless leads

[ad_1]

Pill gross sales fell 10% in 2023 in comparison with 2022, in accordance with newly launched knowledge from Canalys. For the total 12 months, 135.3 million tablets obtained bought. Apple nonetheless leads, as you’d count on, with a whopping 40% market share from its 54 million shipments.

Its market share stayed about flat in comparison with 2022 when it had 40.4% of the pie, and it is a related story for Samsung, which is No.2 – its 25.6 million shipments final 12 months gave it 19% of the pie, in comparison with 19.3% the 12 months earlier than.

Tablet sales keep falling, Apple still leads

In third is Lenovo with 9.3 million gross sales, grabbing 6.9% market share, down from 7.7% in 2022. Subsequent up, Huawei, with 8.3 million shipments and 6.1% market share, and Amazon with 7.7 million bought for a 5.8% share.

Tablet sales keep falling, Apple still leads

Amazon noticed the largest decline in market share, because it had 9.1% in 2022, whereas Huawei was the one model within the High 5 to see any sort of development – it used to have simply 4.2% of the market in 2022.

For the fourth quarter of 2023, Huawei snatched the third place from Lenovo, in any other case the standings are the identical. Apple moved 14.8 million gadgets from October to December for a 39.2% market share, adopted by Samsung with 6.8 million shipments grabbing 18% of the pie. Huawei bought 2.8 million models and Lenovo managed 2.6 million, whereas Amazon rounded up the High 5 with 2 million.

Tablet sales keep falling, Apple still leads

In comparison with This fall 2022, solely Huawei and Lenovo noticed development – a whopping 95.4% for the previous, 14.9% for the latter. Apple’s gross sales fell 24%, Samsung’s by 10%, and Amazon’s by 43.9%. The general pill market in This fall noticed gross sales fall 11% to 37.8 million models.

In line with Canalys researchers, China and India drove gross sales serving to to counter “prevailing stagnation” in different elements of the world. Curiously, the analysts count on the pill market to rebound this 12 months, pushed by “more healthy stock ranges and additional scope for presidency and industrial deployments”. Moreover, this 12 months will see “a higher focus” on foldable tablets, regardless that cargo numbers will not be very excessive as a consequence of their predictably premium pricing.

Supply

[ad_2]

Supply hyperlink

LEAVE A REPLY

Please enter your comment!
Please enter your name here